(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. The Ankyrin-binding and PH domains are not required for axon
guidance. (A-E) Late stage 16 embryos stained with the anti-Fas2
Mab. Anterior is up. (A) ß-spectrin heterozygous embryos have no
Fas2-positive longitudinal bundles crossing the midline. (B)
ß-spectrin (em6) hemizygous embryos display Fas2-positive axons
crossing the midline (arrows). (C) ß-spectrin null hemizygous
embryos ubiquitously expressing full-length ß-Spectrin are rescued for
both the medial ectopic crossing defect and lateral longitudinal breaks. (D)
Ubiquitously expressing a form of ß-Spectrin lacking the Ankyrin-binding
domain (ßSpec
ank) also rescues the midline axon guidance defects
seen in ß-spectrin mutant embryos. (E) Ubiquitously expressing a
form of ß-Spectrin lacking the PH domain (ßSpec
PH) also
rescues ß-spectrin mutant midline guidance errors. (F)
Quantification of ectopic Fas2-positive midline crossovers in
ß-spectrin heterozygous, hemizygous mutant, and transgenic
rescued backgrounds. a, em6/+ (n=15); b, em6/Y
(n=13); c, em6/Y+Ub-ßSpecWT (n=9); d,
em6/Y+Ub-ßSpec
ank (n=15); e,
em6/Y + Ub-ß-Spec
PH (n=20).
Asterisk denotes a significant difference between genotype b and genotypes a,
c, d and e (P=1.22x10-6; two-sample Student's
t-test). Error bars indicate s.e.m. (G-M) Same embryos as in
B-E, stained with the polyclonal anti-Myc antibody. Anti-Myc stainings were
performed at the same time and images were taken at the same confocal
settings. (G) Sibling ß-spectrin mutant embryos not expressing a
transgene do not stain with the Myc antibody. Ubiquitously expressed wild-type
ß-Spectrin localizes to the axons (H) and to the plasma membrane at sites
of cell contact (K). Ubiquitously expressed ßSpec
ank localizes
similarly to full-length transgenic protein to the axon scaffold (I) and to
the plasma membrane (L). Ubiquitously expressed ßSpec
PH localizes
to axons (J), although at reduced levels, but is no longer localized to the
plasma membrane nor at sites of cell contact (M).